Correction to: Clinical and Experimental Nephrology (2019) 23:739–748 10.1007/s10157-019-01692-y
The article “Efficacy and safety of evocalcet in Japanese peritoneal dialysis patients” written by Kazuhiko Tsuruya · Ryutaro Shimazaki · Masafumi Fukagawa · Tadao Akizawa on behalf of Evocalcet Study Group, was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 6th April 2019 without open access.
With the author(s)’ decision to opt for Open Choice the copyright of the article changed on 20th June 2019 to © The Author(s) 2019 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. The original article has been corrected.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Kazuhiko Tsuruya, Phone: +81-744-29-8865, Email: tsuruya@naramed-u.ac.jp.
Evocalcet Study Group:
Yoshimitsu Hayashi, Hidetomo Nakamoto, Shoji Koga, Ichiro Okido, Minoru Kubota, Fumihiko Koiwa, Masahiro Takeda, Terumasa Hayashi, Makoto Hiramatsu, Hideki Kawanishi, Hidetoshi Kanai, Sakuya Ito, Kazuhiko Tsuruya, Koji Mitsuiki, and Hirofumi Ikeda